Basit öğe kaydını göster

dc.contributor.authorCanatan, Duran
dc.contributor.authorYılmaz, Özlem
dc.contributor.authorSönmez, Yonca
dc.contributor.authorBaykara, Mehmet
dc.contributor.authorSavaş, Murat
dc.contributor.authorCoşkun, Hasan Şenol
dc.contributor.authorGöksu, Sema Sezgin
dc.contributor.authorAktekin, Mehmet Rıfkı
dc.date.accessioned2023-07-13T10:46:17Z
dc.date.available2023-07-13T10:46:17Z
dc.date.issued2022
dc.identifier.citationCanatan, D., Yılmaz, O., Sönmez, Y., Baykara, M., Savaş, M., Coşkun, H. Ş., Göksu, S. S. & Aktekin, M. R. (2022). The miR125b as biomarkers in the early diagnosis of bladder cancer. Genetics & Molecular Medicine, 4(1), 1-4.en_US
dc.identifier.issn2689-1077
dc.identifier.urihttp://hdl.handle.net/20.500.12566/1640
dc.description.abstractObjective: Bladder cancer (BCa) is the fifth most common cancer and the second most common urinary tract cancer in worldwide. BCa accounts for 3% of all cancers and is particularly common in developed countries. Material and methods: Eighteen of the 20 patients included in the study were male, 2 were female, mean age was 65.1±12.1(range:37-75) years. The control group consisted of 19 male one female, mean age was 60.3±11.2 (range:40-70) years. A total of seven miRNAs, let-7c, miR-155, miR-125b, miR-141 miR-145, miR 181 and miR 192 were evaluated in two groups. Results: MiRNAs of bladder cancer patients and healthy individuals were compared according to endogenous miR 181 and miR 192 Delta CT values, miR125b values of bladder cancer cases were found to be significantly higher than healthy controls.(p=0.021) In our study, miR125b, which we found specific and sensitive in endogenous controls, was compatible with studies in the literature. As conclusion, we emphasize that mir125b can be used as a predictor in bladder cancer compared with the literature.en_US
dc.description.sponsorshipThe current study was funded by Republic of Turkey, Ministry of Science and Industry, KOSGEB Antalya Directorate within the scope of the project entitled “MicroRNA kits in the early diagnosis of cancer” conducted by AGTC Özel Genetik Sağlık Hizm. Tur. San. Tic. Ltd. Şti. Grand Number: 0080785533en_US
dc.language.isoengen_US
dc.publisherGenetics & Molecular Medicineen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectBladder canceren_US
dc.subjectMesane kanseritr_TR
dc.subjectBiomarkeren_US
dc.subjectBiyobelirteçtr_TR
dc.subjectMicroRNAsen_US
dc.subjectmir125ben_US
dc.titleThe miR125b as biomarkers in the early diagnosis of bladder canceren_US
dc.typeinfo:eu-repo/semantics/articleen_US
dc.relation.publicationcategoryInternational publicationen_US
dc.identifier.volume4
dc.identifier.issue1
dc.identifier.startpage1
dc.identifier.endpage4
dc.contributor.orcid0000-0001-8128-8269 [Canatan, Duran]
dc.contributor.abuauthorCanatan, Duran
dc.contributor.yokid287062 [Canatan, Duran]


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster